Antag Therapeutics: Funding, Investors & Team (Sep 2026)
Antag Therapeutics is a biotechnology company developing metabolic and anti-obesity therapeutic drugs. It offers the development of peptide-based GIP receptor antagonists in order to monitor dietary-related metabolic diseases through the infusion to decrease blood flow and lipid uptake in adipose tissue.
Antag Therapeutics has raised $84.0M across 1 funding round on record, the most recent a Series A of $84.0M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Antag Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Antag Therapeutics Funding Rounds
Antag Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Antag Therapeutics Funding Compared to Other Biotechnology Startups
Antag Therapeutics' latest round of $84.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Antag Therapeutics in Biotechnology and Copenhagen
Companies Similar to Antag Therapeutics
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Antag Therapeutics Funding FAQs
What does Antag Therapeutics do?
Antag Therapeutics is a biotechnology company developing metabolic and anti-obesity therapeutic drugs. It offers the development of peptide-based GIP receptor antagonists in order to monitor dietary-related metabolic diseases through the infusion to decrease blood flow and lipid uptake in adipose tissue.
How much funding has Antag Therapeutics raised?
Antag Therapeutics has raised $84.0M across 1 round on record. The most recent is a Series A of $84.0M announced in Dec 2024.
When did Antag Therapeutics last raise funding?
Antag Therapeutics' most recent funding round on record is a Series A of $84.0M, announced in Dec 2024.
Who founded Antag Therapeutics?
FundedIQ lists Mette Marie Rosenkilde (Founder) at Antag Therapeutics.
Where is Antag Therapeutics headquartered?
Antag Therapeutics is based in Copenhagen, Hovedstaden, Denmark.
How many employees does Antag Therapeutics have?
Antag Therapeutics is in the 1-10 employee band.
How does Antag Therapeutics' funding compare to other Biotechnology startups?
Antag Therapeutics' latest round of $84.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Antag Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Antag Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.